YOLFTbeta
Bio-Works Technologies AB

Bio-Works Technologies AB

BIOWKS · ST · Healthcare / Medical Instruments & Supplies

3.06SEK-0.02 (-0.65%)

Price History

Full chart

Market Stats

Previous Close3.08
Open3.00
Day Range2.91 – 3.17
52-Week Range2.03 – 4.98
Volume52.78K
Market Cap307.27M
P/E (TTM)76.50
Forward P/E0.00
EPS0.04
Dividend Yield0.00%
Beta0.63
50-Day Avg3.30
200-Day Avg3.24

About

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography resins. Its products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMs. Lone Carlbom
  • Employees32
  • HeadquartersVirdings allé 18, Uppsala, Sweden, 754 50, Sweden
  • Websitehttps://www.bio-works.com

Leadership

  • Ms. Lone CarlbomChief Executive Officer
  • Mr. Jan BerglöfCo-Founder & Senior Advisor
  • Mr. Arne HaugeCFO & Head of Support Functions
  • Ms. Helena PahlmSenior Director of Global Quality
  • Ms. Silvia HellstromHead of Quality Assurance
  • Ms. Maria ÅbergHead of Production

Financials

Income Statement

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.54M3.68M4.95M6.56M5.57M7.23M21.91M41.32M43.90M25.46M62.50M
Growth (%)-+138.46%+34.48%+32.72%-15.08%+29.80%+202.88%+88.59%+6.23%-41.99%+145.44%
Cost of Revenue-2.75M-2.88M-270.00K425.00K203.00K3.02M3.35M12.47M17.07M5.45M14.70M
Gross Profit4.29M6.56M5.21M6.14M5.37M4.22M18.56M28.85M26.82M20.02M47.80M
Gross Margin278.02%178.46%105.46%93.52%96.36%58.28%84.71%69.81%61.10%78.60%76.48%
Operating Expense16.53M23.63M28.80M44.28M47.50M49.87M29.52M75.99M82.24M58.01M65.32M
Operating Income-12.24M-17.07M-23.58M-38.14M-42.13M-45.65M-10.96M-47.14M-55.42M-38.00M-17.52M
Operating Margin-793.77%-464.10%-476.87%-581.17%-755.91%-631.10%-50.01%-114.09%-126.25%-149.21%-28.03%
EBITDA-11.41M-15.45M-21.37M-31.02M-40.77M-44.56M-8.88M-46.10M-54.12M-36.76M-16.46M
EBITDA Margin-740.21%-420.04%-432.19%-472.62%-731.49%-616.02%-40.52%-111.57%-123.29%-144.35%-26.33%
Net Income-12.36M-17.16M-23.66M-37.95M-42.11M-44.55M-12.94M-44.95M-56.82M-37.36M-15.25M
Net Income Margin-801.62%-466.60%-478.40%-578.32%-755.66%-615.83%-59.07%-108.79%-129.44%-146.70%-24.39%
R&D--566.00K5.20M419.00K253.00K232.00K----
R&D as % of Total Revenue--11.45%79.23%7.52%3.50%1.06%----
Interest Expense281.00K495.00K98.00K2.00K09.00K18.00K23.00K3.00K9.00K193.00K
Interest Expense % of Total Revenue18.22%13.46%1.98%0.03%0.00%0.12%0.08%0.06%0.01%0.04%0.31%

Balance Sheet

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets24.71M28.08M105.31M67.41M88.02M45.50M120.86M91.61M62.15M52.50M70.76M
Total Liabilities2.30M4.44M5.99M5.76M5.89M8.04M12.35M23.92M18.12M7.91M21.55M
Total Equity22.41M23.64M99.32M61.64M82.13M37.46M108.51M67.69M44.03M44.58M49.21M
Cash10.40M13.14M89.25M54.06M76.40M33.06M102.75M65.88M39.38M34.28M34.93M
Net Debt-10.40M-13.14M-89.25M-54.06M-76.40M-33.06M-102.75M-65.88M-39.38M-34.28M-34.93M

Cash Flow

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-13.12M-14.46M-21.23M-34.69M-40.04M-43.36M-13.37M-39.88M-58.99M-43.17M-18.81M
Investing Cash Flow-2.15M-2.84M-1.98M-781.00K-220.00K-326.00K-942.00K-1.12M-860.00K158.00K-404.00K
Financing Cash Flow-100.00K20.03M99.32M282.00K62.60M348.00K83.96M4.04M33.26M37.75M20.08M
Capital Expenditure2.15M2.84M1.98M781.00K220.00K326.00K942.00K1.12M860.00K8.00K404.00K
Free Cash Flow-15.27M-17.30M-23.22M-35.47M-40.26M-43.69M-14.31M-41.00M-59.85M-43.18M-19.21M
FCF to OCF116.35%119.64%109.34%102.25%100.55%100.75%107.05%102.82%101.46%100.02%102.15%

Earnings

Report DateMay 30, 2019Aug 23, 2019Sep 30, 2019Feb 14, 2020Apr 24, 2020Aug 21, 2020Feb 19, 2021
EPS Estimate-------
EPS Actual-0.52-0.46-0.38-0.36-0.37-0.32-0.79
Surprise-------
TimingPre-marketPre-market-Pre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap307.27M
Enterprise Value288.27M
Trailing P/E76.50
Forward P/E0.00
Price / Sales3.43
Price / Book6.00
EPS0.04
Book Value0.531
Revenue (TTM)89.71M
Gross Profit (TTM)68.23M
EBITDA-1.42M
Profit Margin2.46%
Operating Margin-15.93%
Return on Equity5.32%
Return on Assets-2.16%
Shares Outstanding100.41M
Shares Float44.84M
Beta0.63
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 3, 2019225:217